Skip to main content
SpringerLink
Log in

Novel antitumor mechanisms of curcumin: implication of altered tumor metabolism, reconstituted tumor microenvironment and augmented myelopoiesis

  • Published:
Phytochemistry Reviews Aims and scope Submit manuscript

Abstract

Curcumin, a product of turmeric plant (Curcuma longa), is widely recognized for its antitumor and anti-inflammatory actions. Multiple mechanisms mediate the antitumor actions of curcumin, involving modulation of cell signaling events, manifesting tumor cytostasis and cytotoxicity. However, until recent it was unclear if the antitumor actions of curcumin also implicate modulation of some crucial checkpoints of unique tumor-specific metabolic events and tumor growth regulatory components of tumor microenvironment (TME), which are the focus of emerging antitumor therapeutic strategies. Considering the indispensible role of these hallmarks of cancer in tumor progression, recent studies investigated if curcumin could also therapeutically target one or more of these driving forces of oncogenesis. Investigations strongly indicate that curcumin can alter glucose uptake and its metabolism in tumor cells, leading to an altered pH homeostasis and reversal of lactic acidosis, culminating in induction of apoptosis. Curcumin can also inhibit tumor progression by antagonizing pro-inflammatory cellular and biophysical parameters of TME. Further, curcumin exerts myelopoietic action, owing to the withdrawal of tumor-dependent toxicity and myelosuppression, improved expression of heme-oxygenase and alleviation of the inhibitory actions of anticancer drugs on bone marrow cells. This review compiles the present state of knowledge, with respect to the effect of this wonder drug on tumor metabolism, components of TME and myelopoiesis. The review also predicts the possible impact of these newly understood roles of curcumin in designing of novel therapeutic protocols against cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363–398

    CAS  PubMed  Google Scholar 

  • Aggarwal BB, Kunnumakkara AB, Harikumar KB, Tharakan ST, Sung B, Anand P (2008) Potential of spice-derived phytochemicals for cancer prevention. Planta Med 74:1560–1569

    Article  CAS  PubMed  Google Scholar 

  • Aggarwal BB, Van Kuiken ME, Iyer LH, Harikumar KB, Sung B (2009) Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Exp Biol Med 234:825–849

    Article  CAS  Google Scholar 

  • Aggarwal BB, Yuan W, Li S, Gupta SC (2013) Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric. Mol Nutr Food Res 57:1529–1542

    Article  CAS  PubMed  Google Scholar 

  • Agrawal DK, Mishra PK (2010) Curcumin and its analogues: potential anticancer agents. Med Res Rev 30:818–860

    CAS  PubMed  Google Scholar 

  • Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818

    Article  CAS  PubMed  Google Scholar 

  • Asher GN, Spelman K (2013) Clinical utility of curcumin extract. Altern Ther Health Med 19:20–32

    PubMed  Google Scholar 

  • Baniyash M, Sade-Feldman M, Kanterman J (2013) Chronic inflammation and cancer: suppressing the suppressors. Cancer Immunol Immunother (Epub ahead of print)

  • Bayet-Robert M, Morvan D (2013) Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel. PLoS ONE 8(3):e57971

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon F, Planchat E, Abrial C et al (2010) Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther 9:8–14

    Article  CAS  PubMed  Google Scholar 

  • Bisht K, Choi WH, Park SY, Chung MK, Koh WS (2009) Curcumin enhances non-inflammatory phagocytic activity of RAW264.7 cells. Biochem Biophys Res Commun 379:632–636

    Article  CAS  PubMed  Google Scholar 

  • Cairns R, Papandreou I, Denko N (2006) Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 4:61–70

    Article  CAS  PubMed  Google Scholar 

  • Catalano V, Turdo A, Di Franco S, Dieli F, Todaro M, Stassi G (2013) Tumor and its microenvironment: a synergistic interplay. Semin Cancer Biol 23:522-532

  • Chang YF, Chuang HY, Hsu CH, Liu RS, Gambhir SS, Hwang JJ (2012) Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice. Cancer Prev Res 5:444–452

    Article  CAS  Google Scholar 

  • Chen CC, Sureshbabul M, Chen HW, Lin YS, Lee JY, Hong QS, et al. (2013) Curcumin Suppresses Metastasis via Sp-1, FAK Inhibition, and E-Cadherin Upregulation in Colorectal Cancer. Evid Based Complement Alternat Med 2013:541695

  • Chiu M, Ottaviani L, Bianchi MG, Franchi-Gazzola R, Bussolati O (2012) Towards a metabolic therapy of cancer? Acta Biomed 83:168–176

    CAS  PubMed  Google Scholar 

  • Choi H, Chun YS, Kim SW, Kim MS, Park JW (2006) Curcumin inhibits hypoxia- inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol Pharmacol 70:1664–1671

    Article  CAS  PubMed  Google Scholar 

  • Coimbra M, Isacchi B, van Bloois L, Torano JS, Ket A, Wu X et al (2011) Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. Int J Pharm 416:433–442

    CAS  PubMed  Google Scholar 

  • Darvesh AS, Aggarwal BB, Bishayee A (2012) Curcumin and liver cancer: a review. Curr Pharm Biotechnol 13:218–228

    Article  CAS  PubMed  Google Scholar 

  • Draghiciu, O, Nijman, HW, Daemen, T (2011) From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors. Clin Dev Immunol 2011:439053

  • Fang HY, Chen SB, Guo DJ, Pan SY, Yu ZL (2011) Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells. Phytomedicine 18:697–703

    Article  PubMed  Google Scholar 

  • Ford NA, Lashinger LM, Allott EH, Hursting SD (2013) Mechanistic targets and phytochemical strategies for breaking the obesity-cancer link. Front Oncol 3:209

    Article  PubMed Central  PubMed  Google Scholar 

  • Fraser ST, Midwinter RG, Berger BS, Stocker R (2011) Heme oxygenase-1: a critical link between iron metabolism, erythropoiesis, and development. Adv Hematol 2011:473709. doi:10.1155/2011/473709

    PubMed Central  PubMed  Google Scholar 

  • Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162–174

    CAS  PubMed Central  PubMed  Google Scholar 

  • Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14:1014–1022

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gerhauser C (2013) Cancer chemoprevention and nutriepigenetics: state of the art and future challenges. Top Curr Chem 329:73–132

    Article  CAS  PubMed  Google Scholar 

  • Ghiringhelli F, Rebe C, Hichami A, Delmas D (2012) Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents. Anticancer Agents Med Chem 12:852–873

    Article  CAS  PubMed  Google Scholar 

  • Goel A, Aggarwal BB (2010) Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 62:919–930

    Article  CAS  PubMed  Google Scholar 

  • Gonda TA, Tu S, Wang TC (2009) Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 8:2005–2013

    Article  CAS  PubMed  Google Scholar 

  • Gostner J, Ciardi C, Becker K, Fuchs D, Sucher R (2014) Immunoregulatory impact of food antioxidants. Curr Pharm Des 20:840–849

  • Gu Q, Cai Y, Huang C, Shi Q, Yang H (2012) Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation. Pharmacogn Mag 8:202–208

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gupta SC, Kismali G, Aggarwal BB (2013a) Curcumin, a component of turmeric: from farm to pharmacy. BioFactors 39:2–13

    Article  CAS  PubMed  Google Scholar 

  • Gupta SC, Patchva S, Aggarwal BB (2013b) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15:195–218

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hagemann T, Balkwill F, Lawrence T (2007) Inflammation and cancer: a double-edged sword. Cancer Cell 12:300–301

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

    Article  CAS  PubMed  Google Scholar 

  • Hasima N, Aggarwal BB (2014) Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatment. Curr Med Chem 21(14):1583–94

  • Hu L, Jia Y, Niu F, Jia Z, Yang X, Jiao K (2012) Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle. J Agric Food Chem 60:7137–7141

    Article  CAS  PubMed  Google Scholar 

  • Jagetia GC, Aggarwal BB (2007) “Spicing up” of the immune system by curcumin. J Clin Immunol 27:19–35

    Article  CAS  PubMed  Google Scholar 

  • Kaefer CM, Milner JA (2008) The role of herbs and spices in cancer prevention. J Nutr Biochem 19:347–361

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kaefer CM, Milner JA (2011) Herbs and spices in cancer prevention and treatment. In: Benzie IFF, Wachtel-Galor S (eds) Herbal medicine: biomolecular and clinical aspects, 2nd edn. CRC Press, Boca Raton, FL (Chapter 17)

    Google Scholar 

  • Kappler M, Taubert H, Schubert J, Vordermark D, Eckert AW (2012) The real face of HIF1α in the tumor process. Cell Cycle 11:3932–3936

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kareva I, Hahnfeldt P (2013) The emerging “hallmarks” of metabolic reprogramming and immune evasion: distinct or linked? Cancer Res 73:2737–2742

    Article  CAS  PubMed  Google Scholar 

  • Kaushik G, Kaushik T, Yadav SK, Sharma SK, Ranawat P, Khanduja KL et al (2012) Curcumin sensitizes lung adenocarcinoma cells to apoptosis via intracellular redox status mediated pathway. Indian J Exp Biol 50:853–861

    CAS  PubMed  Google Scholar 

  • Kawakami Y, Yaguchi T, Sumimoto H, Kudo-Saito C, Tsukamoto N, Iwata-Kajihara T et al (2013) Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy. Ann N Y Acad Sci 1284:80–86

    Article  CAS  PubMed  Google Scholar 

  • Kou MC, Chiou SY, Weng CY, Wang L, Ho CT, Wu MJ (2013) Curcuminoids distinctly exhibit antioxidant activities and regulate expression of scavenger receptors and heme oxygenase-1. Mol Nutr Food Res 57:1598–1610

    Article  CAS  PubMed  Google Scholar 

  • Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199–225

    Article  CAS  PubMed  Google Scholar 

  • Liu D, Chen Z (2013) The effect of curcumin on breast cancer cells. J Breast Cancer 16:133–137

    Article  PubMed Central  PubMed  Google Scholar 

  • Lizée G, Overwijk WW, Radvanyi L, Gao J, Sharma P, Hwu P (2013) Harnessing the power of the immune system to target cancer. Annu Rev Med 64:71–90

    Article  PubMed  Google Scholar 

  • Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221–233

    Article  PubMed  Google Scholar 

  • Luo F, Song X, Zhang Y, Chu Y (2011) Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity. Int Immunopharmacol 11:1234–1240

    Article  CAS  PubMed  Google Scholar 

  • Mantovani A, Locati M (2013) Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol 33:1478–1483

    Article  CAS  PubMed  Google Scholar 

  • Monteleone G, Pallone F, Stolfi C (2012) The dual role of inflammation in colon carcinogenesis. Int J Mol Sci 13:11071–11084

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Monti E, Gariboldi MB (2011) HIF-1 as a target for cancer chemotherapy, chemosensitization and chemoprevention. Curr Mol Pharmacol 4:62–77

    Article  CAS  PubMed  Google Scholar 

  • Nagaraju GP, Zhu S, Wen J, Farris AB, Adsay VN, Diaz R, et al. (2013) Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer. Cancer Lett 341:195–203

  • Norris L, Karmokar A, Howells L, Steward WP, Gescher A, Brown K (2013) The role of cancer stem cells in the anti-carcinogenicity of curcumin. Mol Nutr Food Res 57:1630–1637

    Article  CAS  PubMed  Google Scholar 

  • Pal S, Bhattacharyya S, Choudhuri T, Datta GK, Das T, Sa G (2005) Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin. Cancer Detect Prev 29:470–478

    Article  CAS  PubMed  Google Scholar 

  • Papież MA (2013) The influence of curcumin and (−)-epicatechin on the genotoxicity and myelosuppression induced by etoposide in bone marrow cells of male rats. Drug Chem Toxicol 36:93–101

    Article  PubMed  Google Scholar 

  • Park W, Amin AR, Chen ZG, Shin DM (2013) New perspectives of curcumin in cancer prevention. Cancer Prev Res 6:387–400

    Article  CAS  Google Scholar 

  • Parks SK, Chiche J, Pouysségur J (2013) Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 13:611–623

    Article  CAS  PubMed  Google Scholar 

  • Prasad S, Tyagi AK, Aggarwal BB (2014) Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat 46:2–18

    Article  PubMed Central  PubMed  Google Scholar 

  • Priyadarsini KI (2013) Chemical and structural features influencing the biological activity of curcumin. Curr Pharm Des 19:2093–2100

    CAS  PubMed  Google Scholar 

  • Qiu P, Xu L, Gao L, Zhang M, Wang S, Tong S et al (2013) Exploring pyrimidine-substituted curcumin analogues: design, synthesis and effects on EGFR signaling. Bioorg Med Chem 21:5012–5020

    Article  CAS  PubMed  Google Scholar 

  • Qu W, Xiao J, Zhang H, Chen Q, Wang Z, Shi H et al (2013) B19, a Novel monocarbonyl analogue of curcumin, induces human ovarian cancer cell apoptosis via activation of endoplasmic reticulum stress and the autophagy signaling pathway. Int J Biol Sci 9:766–777

    Article  PubMed Central  PubMed  Google Scholar 

  • Rabinovich GA, Gabrilovich D, Sotomayor EM (2007) Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25:267–296

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ravindran J, Subbaraju GV, Ramani MV, Sung B, Aggarwal BB (2010) Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro. Biochem Pharmacol 79:1658–1666

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Roberts NJ, Zhou S, Diaz LA Jr, Holdhoff M (2011) Systemic use of tumor necrosis factor alpha as an anticancer agent. Oncotarget 2:739–751

    PubMed Central  PubMed  Google Scholar 

  • Ruggiero L, Sogno I, Focaccetti C, Bartolini D, Magnani E, Principi E, Noonan DM, Albini A (2012) Effects of diet-derived molecules on the tumor microenvironment. Current Angiogenesis 1:206–214

    Article  CAS  Google Scholar 

  • Saeidnia S, Abdollahi M (2013) Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Toxicol Appl Pharmacol 271:49–63

    Article  CAS  PubMed  Google Scholar 

  • Santel T, Pflug G, Hemdan NY, Schäfer A, Hollenbach M, Buchold M et al (2008) Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activity. PLoS ONE 3(10):e3508

    Article  PubMed Central  PubMed  Google Scholar 

  • Semenza GL (2013) HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 123:3664–3671

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Shahani K, Panyam J (2011) Highly loaded, sustained-release microparticles of curcumin for chemoprevention. J Pharm Sci 110:2599–2609

    Article  Google Scholar 

  • Shehzad A, Wahid F, Lee YS (2010) Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm 343:489–499

    Article  CAS  Google Scholar 

  • Shishodia S (2013) Molecular mechanisms of curcumin action: gene expression. BioFactors 39:37–55

    Article  CAS  PubMed  Google Scholar 

  • Shishodia S, Chaturvedi MM, Aggarwal BB (2007) Role of curcumin in cancer therapy. Curr Probl Cancer 31:243–305

    Article  PubMed  Google Scholar 

  • Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122:787–795

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sinha D, Biswas J, Sung B, Aggarwal BB, Bishayee A (2012) Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Curr Drug Targets 13:1799–1819

    Article  CAS  PubMed  Google Scholar 

  • Solito S, Falisi E, Diaz-Montero CM, Doni A, Pinton L, Rosato A et al (2011) A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 118:2254–2265

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Subramaniam D, Ponnurangam S, Ramamoorthy P, Standing D, Battafarano RJ, Anant S et al (2012) Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS ONE 7(2):e30590

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Tu SP, Jin H, Shi JD, Zhu LM, Suo Y, Lu G, Liu A, Wang TC, Yang CS (2012) Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Cancer Prev Res 5:205–215

    Article  CAS  Google Scholar 

  • Tuttle S, Hertan L, Katz JS (2011) Indian gold treating cancer in the age of nano. Cancer Biol Ther 11:474–476

    Article  CAS  PubMed  Google Scholar 

  • Vaughan RA, Garcia-Smith R, Dorsey J, Griffith JK, Bisoffi M, Trujillo KA (2013) Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells. Int J Cancer 133:2504–2510

    Article  CAS  PubMed  Google Scholar 

  • Vishvakarma NK, Singh SM (2010) Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: implication in antitumor activation of tumor-associated macrophages. Immunol Lett 134:83–92

    Article  CAS  PubMed  Google Scholar 

  • Vishvakarma NK, Singh SM (2011) Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole. Biochimie 93:1786–1796

    Article  CAS  PubMed  Google Scholar 

  • Vishvakarma NK, Kumar A, Singh SM (2011) Role of curcumin-dependent modulation of tumor microenvironment of a murine T cell lymphoma in altered regulation of tumor cell survival. Toxicol Appl Pharmacol 252:298–306

    Article  CAS  PubMed  Google Scholar 

  • Vishvakarma NK, Kumar A, Kumar A, Kant S, Bharti AC, Singh SM (2012) Myelopotentiating effect of curcumin in tumor-bearing host: role of bone marrow resident macrophages. Toxicol Appl Pharmacol 263:111–121

    Article  CAS  PubMed  Google Scholar 

  • Yadav SK, Sah AK, Jha RK, Sah P, Shah DK (2013) Turmeric (curcumin) remedies gastroprotective action. Pharmacogn Rev 7:42–46

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yallapu MM, Ebeling MC, Jaggi M, Chauhan SC (2013) Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab 14:504–515

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yang C, Su X, Liu A, Zhang L, Yu A, Xi Y et al (2013a) Advances in clinical study of curcumin. Curr Pharm Des 19:1966–1973

    CAS  PubMed  Google Scholar 

  • Yang CH, Yue J, Sims M, Pfeffer LM (2013b) The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS ONE 8:e71130

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yin HT, Zhang DG, Wu XL, Huang XE, Chen G (2013) In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev 14:409–412

    Article  PubMed  Google Scholar 

  • Zaidi MR, Merlino G (2011) The two faces of interferon-γ in cancer. Clin Cancer Res 17:6118–6124

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zamarron BF, Chen W (2011) Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 7:651–658

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zhang Q, Zhong Y, Yan LN, Sun X, Gong T, Zhang ZR (2011) Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents. Bioorg Med Chem Lett 21:1010–1014

    Article  CAS  PubMed  Google Scholar 

  • Zhao C, Cai Y, He X, Li J, Zhang L, Wu J et al (2010) Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophages. Eur J Med Chem 45:5773–5780

    Article  CAS  PubMed  Google Scholar 

  • Zlotogorski A, Dayan A, Dayan D, Chaushu G, Salo T, Vered M (2013) Nutraceuticals as new treatment approaches for oral cancer—I: curcumin. Oral Oncol 49:187–191

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The author is grateful to the Department of Botany and Microbiology, HNB Garhwal University, India for facilities required for preparing this manuscript.

Author information

Authors and Affiliations

  1. Department of Biotechnology, Guru Ghasidas Vishwavidyalaya, Koni, Bilaspur, 495009, Chattisgarh, India

    Naveen Kumar Vishvakarma

Authors
  1. Naveen Kumar Vishvakarma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naveen Kumar Vishvakarma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vishvakarma, N.K. Novel antitumor mechanisms of curcumin: implication of altered tumor metabolism, reconstituted tumor microenvironment and augmented myelopoiesis. Phytochem Rev 13, 717–724 (2014). https://doi.org/10.1007/s11101-014-9364-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11101-014-9364-2

Keywords

Search

Navigation